Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw

Medication-related osteonecrosis of the jaw (MRONJ) frequently affects patients after treatments with bisphosphonates or denosumab, especially with high doses in patients with bone osteoporosis, neoplastic metastases, or possibly anti-angiogenic treatment for cancer. The aim of this article was to s...

Full description

Bibliographic Details
Main Authors:	Antonio Cortese, Antonio Casarella, Candace M. Howard, Pier Paolo Claudio
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Dentistry Journal
Subjects:	medication-related osteonecrosis of the jaw fracture mandible osteonecrosis bisphosphonates
Online Access:	https://www.mdpi.com/2304-6767/9/5/50

Similar Items

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis
by: Gabriela Dias Rosso dos Santos, et al.
Published: (2024-11-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review
by: Rahul Mohandas, et al.
Published: (2024-06-01)

The Use of Imaging Methods in the Diagnosis of Bisphosphonate-related Osteonecrosis of the Jaw
by: L. Hauer, et al.
Published: (2012-03-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006-12-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Knowledge Level of Physicians Prescribing Bisphosphonates: Prevention and Treatment of Medication-Related Osteonecrosis of the Jaw
by: Tahereh Padeganeh, et al.
Published: (2024-10-01)

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications
by: Kazuhiko Iwasaki, et al.
Published: (2023-06-01)

OSTEONECROSIS OF THE JAW ASSOCIATED WITH SHORT-COURSE AND LOW-DOSE CORTICOSTEROID THERAPY
by: Lavinia Cristina Pădurariu, et al.
Published: (2023-12-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Prevention and management of drug‐induced osteonecrosis of the jaws using platelet‐rich fibrin: A clinical feasibility study
by: Abdusalam Alrmali, et al.
Published: (2023-10-01)

Medication‐related osteonecrosis of the jaw: Case series and literature review
by: Denis Kimathi, et al.
Published: (2024-04-01)

History and Etiology of Jawbones Osteonecrosis
by: L. Hauer
Published: (2009-12-01)

Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?
by: Gianluca Tenore, et al.
Published: (2020-04-01)

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw
by: Ken Matsunaka, et al.
Published: (2022-08-01)

EPIDEMIOLOGICAL INVESTIGATION OF THE CLINICAL MANIFESTATION OF BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAWS IN 112 ONCOLOGY PATIENTS
by: Meri Hristamyan, et al.
Published: (2025-02-01)

Local re-activation of osteoclast differentiation as a novel therapeutic strategy for osteonecrosis of the jaw
by: Tommaso Zanocco-Marani, et al.
Published: (2024-07-01)

How Surgery Affects Patients with Jaw Osteonecrosis? A Quality of Life Analysis Study
by: Ahmet Biçer, et al.
Published: (2022-04-01)

Post biphosphonate mandible osteonecrosis: A case study and literature review
by: Bambara H. Aboubacar, et al.
Published: (2023-09-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Spontaneous medication-related osteonecrosis of the jaws in a 23-year-Old
by: Brenden J. Manley, et al.
Published: (2023-03-01)

Comparing the effects of low-level laser therapy and gaseous ozone as a preventive measure on medication-related osteonecrosis of the jaws following tooth extraction: a rat model
by: Öznur Özalp, et al.
Published: (2024-07-01)

Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
by: Thomas Ziebart, et al.
Published: (2016-10-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Assessment of Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw Following Reconstructive and Restorative Surgery
by: Kirill Arturovich Polyakov, et al.
Published: (2021-12-01)

Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate
by: Hiroko Okawa, et al.
Published: (2022-08-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)